Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more
SeekingAlpha
SeekingAlpha
SeekingAlpha
SeekingAlpha
Access detailed stock analysis from LSEG including analyst price target estimates.